![Geoffrey Kempler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Kempler
Algemeen Directeur bij
HEXIMA LIMITED
Vermogen: 100 701 $ op 30-09-2026
Profiel
Geoffrey Paul Kempler was the founder of Alterity Therapeutics Ltd., founded in 1997, where the title held was Non-Executive Chairman from 2021 to 2025.
Mr. Kempler is currently Chairman & Managing Director at Hexima Ltd. since 2023.
Former positions include Chairman at Opthea Ltd. from 2015 to 2020 and Chairman at AusBiotech Ltd. from 2021 to 2023.
Education includes undergraduate studies at Monash University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-11-2025 | 359.620 ( 0,16% ) | 100 701 $ | 30-09-2026 |
Actieve functies van Geoffrey Kempler
| Bedrijven | Functie | Begin |
|---|---|---|
| HEXIMA LIMITED | Algemeen Directeur | 05-09-2023 |
Eerdere bekende functies van Geoffrey Kempler
| Bedrijven | Functie | Einde |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Algemeen Directeur | 07-01-2021 |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Voorzitter | 01-11-2023 |
| CERYVYN THERAPEUTICS LIMITED | Voorzitter | 12-10-2020 |
Opleiding van Geoffrey Kempler
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
35
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
